US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

41.77

+0.08000.19%

Post-market: 41.900.1300+0.31%19:30 EDT

Volume:61.84K

Turnover:2.58M

Market Cap:284.04M

PE:- -

High:41.83

Open:41.75

Low:41.21

Close:41.69

52wk High:41.86

52wk Low:22.33

Shares:6.80M

Float Shares:6.80M

Volume Ratio:0.33

T/O Rate:0.91%

Dividend:0.28

Dividend Rate:0.67%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (Zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva

THOMSON REUTERS

Twist Bioscience CEO Emily M. Leproust Disposes of 5,203 Common Shares Worth $921,493.96

FDA approves Incyte’s Atebrioz for fibrodysplasia ossificans progressiva

US FDA Approves Mirum's Drug for Rare Bone Disorder

FDA: Approves Atebrioz (Zilurgisertib) for Fibrodysplasia Ossificans Progressiva in Adults & Pediatric Patients 12 Years + - Website

THOMSON REUTERS

FDA : Atebrioz Recommended Dosage 100 Mg Once Daily

THOMSON REUTERS

NASDAQ New 52-Week Highs and Lows

Innovation is Driving a New Bull Market in Biotech. 16 Ways to Play It, from Our Roundtable Experts.

Moderna (MRNA) Receives a Hold from Bernstein

Vertex Minerals Sets October General Meeting for Shareholders

INLIF Stock Is Trending: Here's Why it Skyrocketed Over 93% After Hours

Benzinga Earnings

Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Moderna Inc Stock (MRNA) Moved Up by 5.91% on Sep 24: What Investors Need To Know

Twist Bioscience Corp Stock (TWST) Moved Up by 11.04% on Sep 24: A Full Analysis

U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

Leerink Sees Life-Science Tools Benefiting from Anthropic's Push into Biology

MediciNova completes LPLV in Phase 2b/3 clinical trial evaluating MN-166

MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/IDNA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":41.77,"timestamp":1790366400000,"preClose":41.69,"halted":0,"volume":61840,"hourTrading":{"tag":"盘后","latestPrice":41.9,"preClose":41.77,"latestTime":"19:30 EDT","volume":2623,"amount":111352.0686,"timestamp":1790379004993,"change":0.13,"changeRate":0.003112,"amplitude":0.029447},"delay":0,"changeRate":0.0019189254017751357,"floatShares":6800000,"shares":6800000,"eps":0,"marketStatus":"Closed","change":0.08,"latestTime":"09-25 16:00:00 EDT","open":41.75,"high":41.828,"low":41.205,"amount":2581118.116,"amplitude":0.014944,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790582400000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":41.69,"sharesOutstanding":5100000,"nav":41.521308,"aum":284420959.8,"dividendRate":0.006696,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":41.5,"preClose":41.69,"latestTime":"07:12 EDT","volume":2,"amount":83,"timestamp":1790334777796,"change":-0.19,"changeRate":-0.004557,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":41.9,"preClose":41.77,"latestTime":"19:30 EDT","volume":2623,"amount":111352.0686,"timestamp":1790379004993,"change":0.13,"changeRate":0.003112,"amplitude":0.029447},"volumeRatio":0.333171,"impliedVol":0.1005,"impliedVolPercentile":0.1793},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6800000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.333171,"shares":6800000,"dividePrice":0.2797,"high":41.828,"amplitude":0.014944,"preClose":41.69,"low":41.205,"week52Low":22.33,"pbRate":"--","week52High":41.86,"institutionHeld":0,"latestPrice":41.77,"eps":0,"divideRate":0.006696,"volume":61840,"delay":0,"ttmEps":0,"open":41.75,"prevYearClose":26.19,"prevWeekClose":39.83,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":39.83,"twentyDayClose":40.6,"sixtyDayClose":33.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670427486","title":"Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (Zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2670427486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670427486?lang=en_us&edition=fundamental","pubTime":"2026-09-26 07:00","pubTimestamp":1790377200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA9XLLCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4139","MIRM","BK4585","IDNA","BK4532","INCY","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670424345","title":"Twist Bioscience CEO Emily M. Leproust Disposes of 5,203 Common Shares Worth $921,493.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2670424345","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670424345?lang=en_us&edition=fundamental","pubTime":"2026-09-26 04:06","pubTimestamp":1790366770,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO Emily M. Leproust disposes of 5,203 common shares worth $921,493.96Twist Bioscience CEO Emily M. Leproust sold 5,203 shares of common stock on Sep. 24, 2026.Sales prices ranged fr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nNDLb8CMCK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience CEO Emily M. Leproust Disposes of 5,203 Common Shares Worth $921,493.96","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","GNOM","IDNA","TWST","ARKG","BK4585","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421169","title":"FDA approves Incyte’s Atebrioz for fibrodysplasia ossificans progressiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421169","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670421169?lang=en_us&edition=fundamental","pubTime":"2026-09-26 03:00","pubTimestamp":1790362813,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration announced it has approved Atebrioz tablets to reduce the volume of total new heterotopic ossification in adul...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-incytes-atebrioz-for-fibrodysplasia-ossificans-progressiva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-incytes-atebrioz-for-fibrodysplasia-ossificans-progressiva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LABU","IDNA","INCY","BK4585","BK4139","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670542159","title":"US FDA Approves Mirum's Drug for Rare Bone Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2670542159","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670542159?lang=en_us&edition=fundamental","pubTime":"2026-09-26 02:57","pubTimestamp":1790362661,"startTime":"0","endTime":"0","summary":"US FDA approves Mirum's drug for rare bone disorderSept 25 (Reuters)-The US Food and Drug Administration has approved Mirum Pharmaceuticals'MIRM.Odrug to treat a rare bone disorder, the regulator said on Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H12T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0320765992.SGD","LU0823434583.USD","LU0823434740.USD","LU1974910355.USD","LU2362541513.USD","LU0889565916.HKD","LU2468319806.SGD","LU0114720955.EUR","BK4532","BK4585","LU2023250504.SGD","LU2362541273.HKD","LU0109394709.USD","LU0289739699.SGD","TBXU","LU1917777945.USD","LU2362540622.SGD","REGN","BBH","IBB","LU0053666078.USD","LU0823416689.USD","BK4139","LU2106854487.HKD","IBBQ","INCY","BK4588","LU2237438978.USD","LU2089984988.USD","BK4550","IDNA","MIRM","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421307","title":"FDA: Approves Atebrioz (Zilurgisertib) for Fibrodysplasia Ossificans Progressiva in Adults & Pediatric Patients 12 Years + - Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670421307?lang=en_us&edition=fundamental","pubTime":"2026-09-26 02:52","pubTimestamp":1790362346,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45H12W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INCY","BK4585","BK4532","BK4139","BK4588","BK4550","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670300421","title":"FDA : Atebrioz Recommended Dosage 100 Mg Once Daily","url":"https://stock-news.laohu8.com/highlight/detail?id=2670300421","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670300421?lang=en_us&edition=fundamental","pubTime":"2026-09-26 02:52","pubTimestamp":1790362346,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45H12W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","INCY","BK4139","BK4532","BK4585","BK4550","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670706429","title":"NASDAQ New 52-Week Highs and Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2670706429","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670706429?lang=en_us&edition=fundamental","pubTime":"2026-09-26 02:22","pubTimestamp":1790360520,"startTime":"0","endTime":"0","summary":"ARC Group Secs Acqn I        FJDIU       10.14         26,835. Gl X Genomics & Biotech      GNOM        70.83         11,765. GrShr 2x Long AMD Daily      AMDL        86.43      1,432,877. Invsc BS 2036 Mun Bd         BSMA        27.15          6,786. Leverage 2X Lg AMD Dly       AMDG       145.58         21,664","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMHX","MRNA","WDNA","FTXL","LU2265009873.SGD","SOXX","TTEQ","LEGR","IE0009356076.USD","LU1267930813.SGD","BK4532","IE00B64PRP62.GBP","BK4554","LU0081259029.USD","LU2896262040.SGD","QID","SGXZ81514606.USD","BK4568","GPIQ","03034","IE00BGHQF748.EUR","BK4139","BK4543","LU1989764664.SGD","AMDW","LU2290526834.HKD","LU2264538146.SGD","SGXZ51526630.SGD","LU0889566641.SGD","WUGI","LU1988902786.USD","LU1951200564.SGD","LU2462591350.SGD","BCDF","LU2461242641.AUD","QQQ","LU0251132253.USD","AMDD","BK4533","SAMD0main","LU1803068979.SGD","LU2361044865.SGD","DAMD","LU2054465674.USD",".IXIC","SG9999014013.SGD","BK4605",".HXC","LU0708995401.HKD","PSI","BK4614","IDNA","MRNX","LU0198837287.USD","03455","09834","LU1861220033.SGD","IE00B3QW5Z07.USD","SGXZ99366536.SGD","SG9999014005.SGD","CHPS","LU1923623000.USD","IE0004445239.USD","SG9999001424.SGD","02834","LU0786609619.USD","LU2089985449.USD","BK4534","AMYY","BK4612","LU2458330243.SGD","LU2098885051.SGD","GNOM","PSQ","LU1267930730.SGD","LU2250418816.HKD","TQQQ","BK4112","AMDS","NOCT","09086","IE00BZ1G4Q59.USD","AMUU","LU1880398471.USD","LU1861559042.SGD","LU0719512351.SGD","ILDR","LU2355687059.USD","TEK","LU0048584097.USD","LU2860962120.EUR","BK4141","IE00BKPKM429.USD","LGHT","MRNY","GAMR","LU2108987350.USD","LU2931357623.SGD","IE00BQXX3C00.GBP","LU0823434583.USD","LU0348723411.USD","AIQ","LU0109391861.USD","QQQA","FAI","BK4551","IE0001KFT4U8.USD","LU2543165471.USD","AMDU","NJAN","BK4585","03086","LU2360106780.USD","AMDC","LU0979878070.USD","07266","LU0127658192.USD","LU1804176565.USD","AIS","IE00BQXX3F31.USD","LU0792757196.USD","LU2236285917.USD","USXF","LU0210536198.USD","QQQX","LU1232071149.USD","LU1880398554.USD","LU1064131342.USD","BK4512","LU2456880835.USD","BK4548","LU1989772840.SGD","SG9999014021.USD","BK4588","LU2458330169.SGD","LU0642271901.SGD","LU1989772923.USD","IE00B1BXHZ80.USD","XNTK","QMAR","LU1303367103.USD","NAPR","LU0823421416.USD","LU0109392836.USD","NDX","07522","LU2361044949.HKD","IE00B5949003.HKD","LU2417539215.USD","LU0082616367.USD","SOXY","NDAQ","IE00BKVL7J92.USD","IE00BMPRXR70.SGD","LU0320765059.SGD","LU2210149790.SGD","SQQQ","BK4529","AMDY","BK4566","LU0314104364.USD","LU2210150020.SGD","LU2242649171.HKD","LU1242518857.USD","LU0133085943.USD","LU0390134368.USD","LU0823434740.USD","QQQM","LU1861215975.USD","BK4575","LU1951198990.SGD","SG9999014039.USD","LU0672654240.SGD","AMD","IETC","LU0823421333.USD","LU0274383776.USD","LU2095319765.USD","LU1852331112.SGD","NJUL","CNAV","LU1242518931.SGD","WISE","07568","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BMPRXN33.USD","IE00BMPRXQ63.HKD","LU1861558580.USD","07261","LU1989764748.USD","TRFK","QLD","AMDL","LU2360107168.USD","LU0889565833.HKD","QDEC","LU0056508442.USD","LU2361045086.USD","BK4501","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","LU1316542783.SGD","LU2247934214.USD","SMH","LU0174119429.USD","BAI","TQQY","BK4573","AMDG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670425143","title":"Innovation is Driving a New Bull Market in Biotech. 16 Ways to Play It, from Our Roundtable Experts.","url":"https://stock-news.laohu8.com/highlight/detail?id=2670425143","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670425143?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:39","pubTimestamp":1790350740,"startTime":"0","endTime":"0","summary":"A tidal wave of innovation in biotechnology is improving patient outcomes, transforming the industry's prospects, and lifting long-suffering biotech shares. Spurred by therapeutic breakthroughs and ne","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BMED","LU0070302665.USD","LU1061106388.HKD","LU2433249047.HKD","LU0203345920.USD","SG9999015358.SGD","SG9999001176.USD","LU0980610538.SGD","IBB","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU1069347547.HKD","LU0289961442.SGD","BK4501","SG9999013999.USD","LU0859254822.USD","LU0006306889.USD","MRNA","LU1941712348.USD","BK4516","LU0320765646.SGD","SGXZ57979304.SGD","BK4139","BK4533","LU2023250843.SGD","LU0058720904.USD","SG9999014567.USD","LU0965509010.AUD","LU2125909247.SGD","LU0689626769.HKD","SG9999015341.SGD","LU0985320562.USD","LU2491050154.USD","BK4568","LU0289739699.SGD","IE0002141913.USD","LU2360032135.SGD","LU0238689110.USD","LU1983299246.USD","IE00BN8TJ469.HKD","LU2125909593.SGD","LU0072461881.USD","LU2324357040.USD","GNOM","IE00BSNM7G36.USD","BK4551","LU2023250504.SGD","HRTS","LU2361044949.HKD","IE00B4R5TH58.HKD","LU2357627491.SGD","IXJ","LU1037948897.HKD","IE00BBT3K403.USD","LU1116320901.HKD","LU1934455277.USD","LU2106854487.HKD","LU1037948541.HKD","LU0511384066.AUD","LU2361045086.USD","IE00BJT1NW94.SGD","LU0942090050.USD","LU1989772840.SGD","LU0965509283.SGD","LU1057294990.SGD","LU2491050071.SGD","LU1917777945.USD","LU1989771016.USD","LU0234572021.USD","BK4534","LU2125154935.USD","VHT","LU1571399168.USD","SG9999014575.USD","LU0266013472.USD","MRNX","LU1430594728.SGD","XBI","WDNA","SG9999001440.SGD","JDOC","XLV","IDNA","GDOC","IE00BLSP4452.SGD","LU0823416689.USD","LU1066051811.HKD","LU2125154778.USD","SG9999001176.SGD","LU1093756168.USD","LU2361044865.SGD","LU0868494708.USD","IE00BFTCPJ56.SGD","LU0069063385.USD","LU2468319806.SGD","LU0203347892.USD","LU0162691827.USD","BK4007","LU0289739343.SGD","IHE","LU2491049909.HKD","LU0265550359.USD","LU1585245621.USD","BK4548","BK4559","IE00B2B36J28.USD","PPH","LU0211331839.USD","LU0208291251.USD","LU1929549753.HKD","FHLC","LU1941712264.USD","BK4585","LU0320765489.SGD","LU1162221912.USD","LU0648001328.SGD","LU1032466523.USD","BK4532","SG9999002224.SGD","LU1201861249.SGD","LU0432979614.USD","LU1923622614.USD","LU1934455863.HKD","LU2112291526.USD","TRUH","LU1989772923.USD","LU0122379950.USD","LU0124676726.USD","LU1934455194.USD","LU0861579265.USD","LU1974910355.USD","FTXH","LU1116320737.USD","LU0130102774.USD","LU0265550946.USD","LGHT","MRK","LU0472753341.HKD","LU0965508806.USD","SG9999002232.USD","LU1066053197.SGD","SG9999014559.SGD","MRNY","IE0009355771.USD","PAWZ","LU1035773651.USD","BK4550","BK4588","IYH","LU0057025933.USD","LU1023059063.AUD","IE00BLSP4239.USD","LU0098860793.USD","LU1093756325.SGD","LU1066051225.USD","SG9999014542.SGD","LU1066051498.USD","LU1699723380.USD","LU2089984988.USD","LU1291159041.SGD","RXL","LU0477156953.USD","LU0106261372.USD","LU0965509101.SGD","LU2461242641.AUD","LU0130517989.USD","LU0868494617.USD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442867","title":"Moderna (MRNA) Receives a Hold from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442867?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:56","pubTimestamp":1790333800,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Hold rating on Moderna yesterday and set a price target of $45.00. The company’s shares closed yester...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/moderna-mrna-receives-a-hold-from-bernstein-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/moderna-mrna-receives-a-hold-from-bernstein-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","BK4501","BK4548","IDNA","LGHT","BK4534","MRNY","BK4139","BK4532","BK4585","GNOM","WDNA","BK4588","BK4568","MRNX","BK4551","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670445433","title":"Vertex Minerals Sets October General Meeting for Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2670445433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670445433?lang=en_us&edition=fundamental","pubTime":"2026-09-25 15:37","pubTimestamp":1790321843,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has issued an update. Vertex Minerals Ltd. is an Australian-listed resources company trading on the ASX under th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-sets-october-general-meeting-for-shareholders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-sets-october-general-meeting-for-shareholders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.SGD","BK4532","PBE","IE0002270589.USD","LU0320765992.SGD","LU0889565916.HKD","LU1093756325.SGD","VERX","LU1069344957.HKD","LU0109394709.USD","IE00B4R5TH58.HKD","LU1674673428.USD","VRTX","LU0432979614.USD","LU0058720904.USD","IDNA","LU1430594728.SGD","LU1035775433.USD","BK4139","LU1585245621.USD","IE00B19Z9P08.USD","LU0823416689.USD","IBB","LU2236285917.USD","IE00B19Z9Z06.USD","LU2324357040.USD","LU1559883803.SGD","LU2462157665.USD","IE00BFTCPJ56.SGD","BIB","IE00BZ9MQY76.HKD","SG9999001176.USD","GNMX","IE00B894F039.SGD","LU1674673691.USD","IE0002141913.USD","IE0009355771.USD","TBXU","LU0417517546.SGD","LU2468319806.SGD","LU0234570918.USD","LU0061475181.USD","LU1093756168.USD","BK4585","BBH","LU2417539215.USD","LU2362540622.SGD","MTX","IE00B19Z3B42.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670417369","title":"INLIF Stock Is Trending: Here's Why it Skyrocketed Over 93% After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2670417369","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670417369?lang=en_us&edition=fundamental","pubTime":"2026-09-25 11:49","pubTimestamp":1790308178,"startTime":"0","endTime":"0","summary":"INLIF shares soared 93% after hours Thursday following strong first-half revenue growth and a return to profitability.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/09/61988300/inlif-stock-jumps-93-percent-after-hours-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","IDNA","BK4501","MRNA","BETZ","BK4161","ODDS","BK4139","ODDZ","RSI","INLF","BK4588","LGHT","BK4568","BK4533","BK4551","BK4534","WDNA","GNOM","BK4585","BK4150","BK4532","MRNY","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670415347","title":"Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2670415347","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670415347?lang=en_us&edition=fundamental","pubTime":"2026-09-25 06:00","pubTimestamp":1790287241,"startTime":"0","endTime":"0","summary":"Revolution Medicines director Elizabeth M. Anderson disposes of $1,949,321.86 in common sharesElizabeth M. Anderson, director, cut her direct stake in Revolution Medicines common stock to 4,333 shares","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL3Nb1nM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","IE00BFTCPJ56.SGD","IDNA","RVMD","LU0889565916.HKD","IE0009354923.USD","IE0009355771.USD","IE0002141913.USD","BK4139","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD","PTH","IE00B2B36J28.USD","BBH","IE00B4R5TH58.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670184794","title":"Moderna Inc. Stock Advances 7.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670184794","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670184794?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:33","pubTimestamp":1790281980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 7.0% to $194.82 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 26,939.37 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $192.31, which the company reached on September 23rd.The stock outperformed some of its peers, as Johnson & Johnson rose 0.6% to $270.68, Pfizer Inc. rose 0.8% to $28.41, and Gilead Sciences Inc. fell 1.11% to $149.69.Trading volume totaled 16.4 million, compared to the 50-day average of 18.6 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LGHT","LU1057294990.SGD","LU1571399168.USD","LU1674673428.USD","LU0234570918.USD","LU1430594728.SGD","IDNA","BBH","LU1061106388.HKD","LU2324357040.USD","BK4551","GILD","LU1066053197.SGD","MRNY","LU0965508806.USD","BK4533","LU0965509283.SGD","LU1778281490.HKD","BK4550","IBB","LU0861579265.USD","LU0965509010.AUD","LU0965509101.SGD","IE00B19Z3B42.SGD","MRNA","LU2357627491.SGD","IBBQ","BMED","WDNA","MRNX","BK4534","IE00B19Z3581.USD","BK4568","MEDI","LU0289739699.SGD","TBXU","IE00BZ1G4Q59.USD","LU0859254822.USD","LU2112291526.USD","TMED","IE00B3T34201.USD","BIB","SG9999015952.SGD","LU1934455863.HKD","LU2468319806.SGD","IE0002270589.USD","GNOM","LU1066051498.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670909974","title":"Moderna Inc Stock (MRNA) Moved Up by 5.91% on Sep 24: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2670909974","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670909974?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:15","pubTimestamp":1790277319,"startTime":"0","endTime":"0","summary":"• Moderna shares rose as investors welcomed its transformation into a diversified biotechnology platform.\n• Anticipation for Phase 3 oncology trial data and new respiratory approvals drove buying pressure.\n• The company reported $1.94 billion in annual revenue and a net loss.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262185597-market-movers-mrna-20260924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4139","BK4585","BK4588","IDNA","BK4548","BK4532","GNOM","BK4534","MRNX","BK4568","BK4551","WDNA","MRNY","MRNA","BK4501","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669496278","title":"Twist Bioscience Corp Stock (TWST) Moved Up by 11.04% on Sep 24: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669496278","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669496278?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:15","pubTimestamp":1790259319,"startTime":"0","endTime":"0","summary":"• Twist partnered with Eli Lilly to integrate data into TuneLab.\n• Third-quarter results showed double-digit revenue growth and improved margins.\n• Annual revenue reached $376.57M alongside a net loss of $77.67M.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262185189-market-movers-twst-20260924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","WDNA","BK4588","IDNA","ARKG","BK4585","BK4139","TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669446047","title":"U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants","url":"https://stock-news.laohu8.com/highlight/detail?id=2669446047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669446047?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:12","pubTimestamp":1790251979,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Everpure, Dropbox, Darden RestaurantsSeptember 24 (Reuters)-Wall Street futures dropped on Thursday as the Middle East conflict remained far from a resolution, while inves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL6N45G0Q9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","LU2394011477.USD","LU0154245756.USD","TLT","LU0323239441.USD","LU1815336760.USD","BK4129","TSYW","LU0154245673.USD","BK4023","TLTX","IEI","LU2087625088.SGD","BK4581","ARKG","BK4209","ACAD","IEF","LU0353189680.USD","TLH","TBJL","BWZ","LU2065170008.USD","TFJL","BK4585","P","ISHG","LU1093756325.SGD","BK4139","BK4598","TLTI","IDNA","BK4588","FLGV","BK4504","LU0444971666.USD","BK4528","GNOM","LU2065171311.SGD","GRML","THNR","LU1804176565.USD","SG9999001440.SGD","KYTX","LU1261432733.SGD","ZAP","LU1642822529.SGD","PWR","SGOV","LU1571399168.USD","PUL","VKTX","POW","GRID","BK4532","BBLB","SFIX","LU1917777945.USD","BK4534","BBIB","DBX","LU2023250843.SGD","BK4122","LU2065171402.SGD","HWAY","LU0323240290.USD","BBSB","BWX","DRI","BK4551","LU2023250504.SGD","BK4170","LU2265009873.SGD","SHY","ODDZ","BK4094","BK4599","BK4567","LU0957808578.USD","JOUL","LU2065169927.USD","WDNA","TWST","SHV","BK4561","POWR","LU0353189763.USD","OZEM","LU1093756168.USD","IGOV","LU1974910355.USD","TLTW","LU2237438978.USD","MGM","BK4150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669934134","title":"Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2669934134","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669934134?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":"Montreal Heart Institute Joins Multinational Study Evaluating a Self-Administered 70 mg Repeat-Dose Regimen of EtripamilMONTREAL and CHARLOTTE, N.C., Sept.  24, 2026 (GLOBE NEWSWIRE) -- Milestone Phar","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368250/0/en/milestone-pharmaceuticals-enrolls-first-canadian-study-participant-in-revera-301-phase-3-pivotal-trial-evaluating-etripamil-nasal-spray-for-afib-rvr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","BK4129","NVIB","HYLG","ECG","BK4585","AV","BK4588","VR","LABU","LU1559883803.SGD","GDOC","MEDX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669462947","title":"Leerink Sees Life-Science Tools Benefiting from Anthropic's Push into Biology","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462947","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669462947?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:04","pubTimestamp":1790247866,"startTime":"0","endTime":"0","summary":"BUZZ-Leerink sees life-science tools benefiting from Anthropic's push into biology** Leerink Partners says Anthropic's growing focus on biology could boost demand for laboratory automation, experiments and large-scale data needed to validate AI predictions** Brokerage sees biotech firm Twist BioscienceTWST.Oas the \"single most important beneficiary\", citing demand for synthetic DNA used to turn AI-designed proteins into testable molecules** Says Anthropic is funding laboratory testing of 5,000 protein designs using Twist's synthetic DNA, highlighting the company's role in AI-driven drug discovery** Leerink says Anthropic's Claude analyzed complex laboratory data in 19-23 minutes, potentially allowing researchers to move more quickly to subsequent experiments** Brokerage says early protein-design results are promising, but more data and lab testing will be needed to develop formats suitable for medicines","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G0U3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST","ARKG","IDNA","GNOM","WDNA","BK4585","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461761","title":"MediciNova completes LPLV in Phase 2b/3 clinical trial evaluating MN-166","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461761","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669461761?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:10","pubTimestamp":1790244648,"startTime":"0","endTime":"0","summary":"MediciNova (MNOV) announced the completion of the last patient, last visit in the double-blind portion of COMBAT-ALS, a Phase 2b/3 clinical trial e...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicinova-completes-lplv-in-phase-2b-3-clinical-trial-evaluating-mn-166-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicinova-completes-lplv-in-phase-2b-3-clinical-trial-evaluating-mn-166-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HYLG","BK4139","IDNA","MEDX","MNOV","GDOC","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461514","title":"MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461514","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669461514?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:00","pubTimestamp":1790244000,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Sept.  24, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchang","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368112/7767/en/medicinova-announces-completion-of-last-patient-last-visit-in-the-double-blind-portion-of-the-phase-2b-3-combat-als-trial-of-mn-166-ibudilast.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","MEDX","IE00B3S45H60.SGD","BK4588","BMED","CAFS","BK4581","LU0006306889.USD","LU0106831901.USD","LU0795875086.SGD","LU0320765646.SGD","LU1720051017.SGD","LU1988902786.USD","LU0557290698.USD","LU1363072403.SGD","LU1989772840.SGD","GDOC","LU2264538146.SGD","EMA","LU0106261372.USD","LU0528227936.USD","LU1732800096.USD","LU0314104364.USD","ARDS","LU1720051108.HKD","KBWB","MNOV","LU0971096721.USD","NVIB","LU2089283258.USD","LU1244550221.USD","HYLG","BK4516","LU0053666078.USD","IE00BKVL7J92.USD","LU0882574139.USD","LU1162221912.USD","BK4504","LU0158827781.USD","LU0210528500.USD","LU0225283273.USD","LU2023251221.USD","LU2111349929.HKD","LU2133065610.SGD","LU2357305700.SGD","LU1244550577.SGD","LU0795875169.SGD","LU0234570918.USD","IAI","IDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}